Estimates Revisions DexCom, Inc. Xetra
Stocks
DC4
US2521311074
Medical Equipment, Supplies & Distribution
|
Market Closed -
Xetra
11:35:33 2026-08-21 am EDT
|
After hours 03:09:37 pm | |||
| 78.00 EUR | +0.52% |
|
78.70 | +0.90% |
| Aug. 13 | Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating | MT |
| Aug. 04 | Argus Adjusts Price Target on DexCom to $96 From $86, Maintains Buy Rating | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- DXCM Stock
- DC4 Stock
- Consensus DexCom, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
